Jade Biosciences (JBIO) Misses Q2 EPS by 11c

Jade Biosciences (NASDAQ: JBIO) reported Q2 EPS of ($0.76), $0.11 worse than the analyst estimate of ($0.65).

For earnings history and earnings-related data on Jade Biosciences (JBIO) click here.

You May Also Be Interested In

• Deutsche Bank cuts Novo Nordisk to Sell after earnings, shares dip
• Active options: SPCX AMD NFLX META MRVL NOW MSFT MSTR IREN OKTA NBIS
• Increasing unusual put volume: HRL PAGP DKS URBN ANF SPYM WMB APO NTNX OKTA PLAY BURL DLTR JMIA CMI PLD BBY